HK1203369A1 - Combination treatment comprising sulphated glycosaminoglycans for inducing labor - Google Patents

Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Info

Publication number
HK1203369A1
HK1203369A1 HK15103908.8A HK15103908A HK1203369A1 HK 1203369 A1 HK1203369 A1 HK 1203369A1 HK 15103908 A HK15103908 A HK 15103908A HK 1203369 A1 HK1203369 A1 HK 1203369A1
Authority
HK
Hong Kong
Prior art keywords
combination treatment
inducing labor
sulphated glycosaminoglycans
sulphated
glycosaminoglycans
Prior art date
Application number
HK15103908.8A
Other languages
English (en)
Chinese (zh)
Inventor
‧埃克曼-奧德貝格
‧馬爾姆斯特倫
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of HK1203369A1 publication Critical patent/HK1203369A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15103908.8A 2012-03-26 2015-04-22 Combination treatment comprising sulphated glycosaminoglycans for inducing labor HK1203369A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
HK1203369A1 true HK1203369A1 (en) 2015-10-30

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103908.8A HK1203369A1 (en) 2012-03-26 2015-04-22 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Country Status (15)

Country Link
US (1) US20150045322A1 (xx)
EP (1) EP2830635A4 (xx)
JP (1) JP6234989B2 (xx)
CN (1) CN104203256B (xx)
AU (1) AU2013240597A1 (xx)
CA (1) CA2868444A1 (xx)
HK (1) HK1203369A1 (xx)
IL (1) IL234689A0 (xx)
MX (1) MX2014011505A (xx)
MY (1) MY175743A (xx)
RU (1) RU2014143017A (xx)
SG (1) SG11201406119WA (xx)
UA (1) UA117908C2 (xx)
WO (1) WO2013147689A1 (xx)
ZA (1) ZA201406901B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
EP2794665B1 (en) 2011-12-19 2017-11-22 Dilafor AB Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
AU2013260209A1 (en) * 2012-05-08 2014-11-20 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
CA3169421A1 (en) 2020-02-17 2021-08-26 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
TW202406559A (zh) 2022-05-03 2024-02-16 瑞典商迪拉佛公司 塔夫西肝素(tafoxiparin)之新穎醫藥用途
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
EP2786233A1 (en) * 2011-11-28 2014-10-08 Corning Incorporated Robust optical touch-screen systems and methods using a planar transparent sheet
EP2794665B1 (en) * 2011-12-19 2017-11-22 Dilafor AB Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Also Published As

Publication number Publication date
SG11201406119WA (en) 2014-11-27
IL234689A0 (en) 2014-11-30
JP2015511664A (ja) 2015-04-20
EP2830635A1 (en) 2015-02-04
EP2830635A4 (en) 2016-03-16
UA117908C2 (uk) 2018-10-25
MX2014011505A (es) 2014-12-05
WO2013147689A1 (en) 2013-10-03
CN104203256B (zh) 2017-11-24
AU2013240597A1 (en) 2014-10-16
RU2014143017A (ru) 2016-05-20
CA2868444A1 (en) 2013-10-03
MY175743A (en) 2020-07-07
US20150045322A1 (en) 2015-02-12
ZA201406901B (en) 2017-09-27
JP6234989B2 (ja) 2017-11-22
CN104203256A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
EP2862620A4 (en) SYSTEM FOR TREATING DISCHARGE GAS
EP2692278A4 (en) Borescope
EP2823830A4 (en) MESH-HIGHNESS MEDIUM
EP2656779A4 (en) ENDOSCOPE
HK1212617A1 (zh) 白癜風的治療
EP2897613A4 (en) TREATMENT COMPOSITIONS
HK1203369A1 (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
EP2777576A4 (en) TREATMENT SYSTEM
EP2803328A4 (en) TREATMENT SYSTEM
EP2789306A4 (en) TREATMENT SYSTEM
EP2806954A4 (en) DISTRIBUTED RATING SYSTEM
GB201212900D0 (en) Triage scoring system
EP2889035A4 (en) ANTI-TUMOR AGENT
EP2721991A4 (en) ENDOSCOPE
HK1214505A1 (zh) 治療方案
GB201204981D0 (en) Pre-harvest treatment
IL217807A0 (en) Therapeutic compositions
GB201201805D0 (en) Speculum
HK1204977A1 (en) Treatment for high cholesterol
GB2503675B (en) Brackets
GB2498997B (en) Oven cleaning system
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment
GB201212604D0 (en) New treatment
GB201216539D0 (en) Epithelial treatment